Status:
UNKNOWN
Ventilator-Associated Pneumonia (VAP) in Intensive Care Unit (ICU)
Lead Sponsor:
University of Thessaly
Conditions:
Ventilator-Associated Pneumonia
Eligibility:
All Genders
14+ years
Brief Summary
Ventilator-associated pneumonia (VAP) is very common in the intensive care unit (ICU), affecting 9 to 40% of ICU patients and mortality rates range from 20 to 50% and may reach more than 70% when the ...
Detailed Description
INTRODUCTION Ventilator-associated pneumonia (VAP) typically refers to nosocomial pneumonia developing 48 hours later from endotracheal intubation and mechanical ventilation.ICU patients who receive ...
Eligibility Criteria
Inclusion
- Presence in intensive care unit receive mechanical ventilation \<48h have no history of ΑRDS or other respiratory disease
Exclusion
- Length of stay \<24 hours
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2011
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00935285
Start Date
July 1 2009
End Date
August 1 2011
Last Update
July 9 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zakynthinos
Larissa, Mezourlo, Greece, 41335